WWII drug can 'double' Tamiflu supply for avian flu

By
November 1, 2005 22:55
2 minute read.

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Two days after the government approved the purchase of NIS 150 million worth of Tamiflu to treat victims of avian flu, the British journal Nature reported on a way to cut dosage of the precious drug in half: It should be given along with a specific generic drug that stops Tamiflu from being excreted in the urine. The "helper" drug, called probenecid, stops many drugs - including antibiotics - from being removed from the blood by the kidneys. The technique was invented during World War II, but probenecid is still widely used alongside antibiotics in emergency rooms and in treating the sexually transmitted diseases gonorrhea and syphilis. The prospect of using the drug to stretch supplies of Tamiflu (oseltamivir phosphate) - which is in very short supply around the world - was raised last week by an unnamed emergency medicine specialist who was browsing safety data published by Tamiflu's Swiss manufacturer. He noticed that giving the flu drug with probenecid doubles the number of hours its active ingredient stays in the blood and doubles its maximum concentration in the blood. In other words, half a dose of Tamiflu with probenecid has the same effect as a dose without. "It dawned on me that the data potentially represented a tremendous therapeutic benefit," the specialist said Tuesday. Doctors have welcomed the idea, telling Nature that the combination therapy raised few safety considerations because probenecid was already so widely used. But some cautioned that, although using probenecid would make Tamiflu go further in emergency situations, coping with a large-scale pandemic still required a huge increase in the production of flu drugs. The World Health Organization and the US Food and Drug Administration declined to comment on the idea, an apparent lack of interest that scientists have described as "stupefying." The possibility of effectively doubling Tamiflu stocks comes just as US President George Bush is preparing to announce the US pandemic plan at the National Institutes of Health.

Related Content

Jisr az-Zarq
April 3, 2014
Residents of Jisr az-Zarqa beckon Israel Trail hikers to enjoy their town

By SHARON UDASIN